参考文献 [1] GBD 2019 Risk Factors Collaborators.
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic
analysis for the Global Burden of Disease Study 2019[]. Lancet, 2020,396(10258):1223-1249
DOI:10.1016/S0140-6736(20)30752-2. [2] Loos R, Yeo G. The genetics of obesity:
from discovery to biology[J]. Nat Rev Genet, 2022.
23(2):120-133.DOI:10.1038/s41576-021-00414-z. [3] Pan X F, Wang L, Pan A. Epidemiology
and determinants of obesity in China[J]. Lancet Diabetes Endocrinol, 2021 ,9(6):373-392.DOI:10.1016/S2213-8587(21)00045-0. [4] Miller H L, Tauber M Lawson E A, et al.
Hypothalamic syndrome[J]. Nat Rev Dis Primers, 2022, 8(1):24. DOI:10.1038/s4
1572-022-00351-z. [5] Rosen C J Antagonizing the Leptin
Receptor in Obesity[J]. N Engl J Med,2023,
388(24):2291-2293.DOI:10.1056NEJMe2301915. [6] Lei Y, Liang X, Sun Y, et al.
Region-specific transcriptomic responses to obesity and diabetes In macaque hypothalamus[J].Cell Metab,2024,36(2)-:438-453.DO:10.
1016/j .met.2024.01.003. [7] Wu Q, Liang X, Wang K, et al.
Intestinal hypoxia- inducible factor 2a regulates lactate levels To shape the gut microbiome and alter
thermogenesis[J]. Cell Metab,2021,33(10):1988-2003.DOI:10.1016/j.cmet.
2021.07.007. [8] Huang X, Li X, Shen H, et al.
Transcriptional repression of beige fat innervation via a YAP/TAZ-S100B
axis[J]. Nat Commun, 2023,14(1):7102 DOI:10.1038/s41467-023 43021-8. [9] Wells J C, Sawaya A L, Wibaek R, et al.
The double burden of malnutition: aetiological Pathways and consequences
for health[J].Lancet,2020,395(10217):75-88 .DOI:10.1016/S0140-6736(19)32472-9. [10] Li V L, He Y, Contrepois K, et al. An exercise
-inducible metabolite that suppresses feeding and obesity[J] Nature, 2022
,606(7915):785-790.DOI:10.1038/s41586-022-04828-5. [11] ChowL S, Gerszten R E, Taylor J M, et al.
Exerkines in health, resilience and disease[J]. Nat Rev Endocrinol, 2022,
18(5):273- 289.DOI:10.1038/s41574-022-00641-2. [12] Russell G，
Lightman S. The human stress response[J]. Nat Rev Endocrinol,2019,15(9):525-
534.DOI:10.1038/s41574-019-0228-0. [13] Scherer T, Sakamoto K, Buettner C.
Brain insulin signaling in metabolic homeostasis and disease[J]. Nat
Rev Endocrinol, 2021,17(8):468 483.DOI:10.1038/s41574-021 -00498-x. [14] Chaput J P. McHill A W. Cox R C, et
al. The role of insufficient sleep and circadian misalignment in obesity[J]. Nat
Rev .Endocrinol,2023,19(2):82-97.DOI:10.1038/s41574-022-00747-7. [15] Tomlinson J W, Tchernof A. Special
issue on Steroids in Obesity and Diabetes[J]. J Steroid Biochem Mol Biol,
2010,122(1-3):1-2 DOI:10.1016/j. jsbmb.2010.08 002. [16] Clutter W E. Screening for Cushing's
syndrome in an era of epidemic obesity[J]. Mo Med, 201
1,108(2):104-106 [17] Goknar N, Webb H, Waters A, et al
Long-term obesity prevalence and linear growth in children with
idiopathic nephrotic syndrome: is normal growth and weight control possible with
steroid-sparing drugs and low-dose steroids for relapses?[J]. Pediatr Nephrol, 2022.
37(7):1575-1584.DOI:10.1007/s00467-021-05288-1. [18] Wang K, Zhang Z, Hang J, et al.
Microbial-host isozyme analyses reveal microbial DPP4 as a potential antidiabetic
target[J]. Science,2023, 381(6657):eadd5787.DOI:10.1 126/science add5787. [19] Wang Y, Zhao L, Gao L, et al. Health
policy and public health implications of obesity in China[].Lancet Diabetes
Endocrinol,2021.9(7):446 461.DOI:10.1016/S2213-8587(21)00118-2. [20] 国家卫生健康委员会、《中国居民营养与慢性病状况报告(2020年)》[EB/OL]. htp://www.gov
.cn/xinwen/2020-12/24/content_ 5572983 .htm. [21] Wang L, Zhou B, Zhao Z, et al. Body-mass index
and obesity in urban and rural China: findings from
consecutive nationally representative surveys during 2004-18[J]. Lancet,2021,398(10294):53-63
.DOI:10.1016/S0140-6736(21)00798-4. [22] Chen K, Shen Z, Gu W, et al.
Prevalence of obesity and associated complications in China: A cross-sectional,
real-world study in 15.8 million adults[J]. Diabetes Obes Metab,2023,25(11):3390-3399
.DOI:10.1111/dom 15238. [23] Obesity: preventing and managing the
global epidemic. Report of a WHO consultation[J] World Health Organ
Tech Rep Ser, 2000,894:1-253 [24] Shi H Clegg D J Sex differences in the
regulation of body weight[J]. Physiol Behav,2009.97(2):199-204 DOI:10.1016/j
physbeh 2009 02.017. [25] Mechanick JI, Hurley D L, Garvey W T.
Adiposity- based chronic disease as a new diagnostic term: the American
Association of Clinical Endocrinologists and American College of Endocrinology position
statement[J]. Endocr Pract,201 7,23(3):372-378.DOI:10.4158/EP161688.PS. [26] Norgan N G, Ferro-Luzzi A. Weightheight
indices as estimators of fatness in men[J]. Hum Nutr Clin Nutr, 1982
,36(5):363-372 [27] Keys A, Fidanza F, Karvonen M J, et
al. Indices of relative weight and obesity[J]. Int J Epidemiol, 2014,43):655-665.
DOI:10.1093/je/dyu058. [28] MansonJ E, Willett W C, Stampfer M J,
et al. Body weight and mortality among women[J]. N Engl J Med,
1995,333(1 1):677-685.DOI:10.1056NEJM199509143331101. [29] Wang Y, Monteiro C, Popkin B M Trends
of obesity and underweight in older children and adolescents in the
United States， Brazil, China, and Russia[J]. Am J Clin Nutr,2002,75(6):971-977.DOI:10.1093/ajcn/75.6.971. [30]
中华人民共和国卫生和计划生育委员会. WS/T 428-2013成人体重判定[S]. 北京:中国标准出版社, 2013. [31] Appropriate body-mass index for Asian
populations and its implications for policy and Intervention strategies[J].Lancet,2004,363(9403):157-163.DOI:10.1016/S0140-6736(03)15268-3. [32] Garvey W T，Mechanick
J I， Brett E M, et al. American association of clinical endocrinologists
and American college of endocrinology comprehensive clinical practice guidelines
for medical care of patients with obesity[J]. Endocr Pract, 2016.,22 Suppl 3:1-203.DOI:10.4158/EP161365.GL. [33] Miller M J, Braun W, Enderle J, et al. Beyond
BM: Conceptual Issues Related to Overweight and Obese Patients[J]. Obes Facts,
2016,9(3):193-205.DOI10.1159/000445380. [34] Neeland I J, Ross R Despres J P, et al
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a positionstatement[J].Lancet
Diabetes Endocrinol,2019.7(9):715-725.DOI:10.1016/S2213-8587(19)30084-1.
|
